Spinout Active LTD

Company profile

Nevrargenics Limited

UK company 12369627, incorporated on 18 December 2019.

Nevrargenics - novel drugs for neurodegenerative diseases

Developing novel treatments for neurodegeneration

Company number
12369627
Incorporated
18 Dec 2019
Companies House status
Active

Company identity

Browse spinouts
Founded / incorporated
18 December 2019

Company number 12369627

Verify at Companies House
Legal name
NEVRARGENICS LIMITED
Company type
Private Limited Company
Region
North East England
Registered address
ORBIT, NETPARK JOSEPH SWAN ROAD
SEDGEFIELD
STOCKTON-ON-TEES
ENGLAND
TS21 3FB
Insolvency history
No

Latest accounts

Financial period: 1 Jan 2024 to 31 Dec 2024

FULLACCOUNTS
Turnover
Unknown
Profit / Loss
Unknown
Employees
3

Company events

Reference milestones and recent Companies House filing stream events.

7 events
30 Sep
2027

Accounts due

Accounts Due

Next accounts due date

06 Feb
2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

30 Sep
2026

Capital Allotment Shares

Capital

SH01 | Transaction MzU0ODQ1ODUxNGFkaXF6a2N4

Published 30 Sep 2026 08:58

21 Sep
2026

Appoint Person Director Company With Name Date

Officers

AP01 | Transaction MzU0NjAzMjAwNGFkaXF6a2N4

Published 21 Sep 2026 12:06

23 Jan
2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Dec
2025

Accounts filed

Accounts

Last accounts made up date

18 Dec
2019

Incorporated

Inception

Company registered at Companies House

Spinout profile

3 entries

Company description

Nevrargenics discovers and develops pharmaceuticals for neurodegenerative diseases.

RAR-M Therapeutics focuses on the development of dual-acting, Retinoic Acid Receptor-Modulators as lead potential drugs for developing a rational and effective new treatment regime for ALS and with the future goal of treatments for other neurodegenerative disorders such as Alzheimer's disease.

Project impact

Company only started end of December 2019

Nevrargenics
2019
Nevrargenics
2019
RAR-M THERAPEUTICS LIMITED
2019